Titleist Asset Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Titleist Asset Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$794K	Sell	5,016 -21	-0.4%	-$2.84K	0.05%	223
2026 Q1	$643K	Sell	5,037 -575	-10%	-$71.8K	0.05%	231
2025 Q4	$684K	Sell	5,612 -81	-1%	-$9.29K	0.06%	188
2025 Q3	$570K	Hold	5,693	–	–	0.05%	191
2025 Q2	$472K	Hold	5,693	–	–	0.05%	210
2025 Q1	$462K	Sell	5,693 -7,656	-57%	-$684K	0.05%	197
2024 Q4	$1.2M	Sell	13,349 -281	-2%	-$27.2K	0.14%	114
2024 Q3	$1.35M	Sell	13,630 -5,903	-30%	-$580K	0.19%	90
2024 Q2	$1.81M	Buy	19,533 +691	+4%	+$62K	0.27%	79
2024 Q1	$1.79M	Buy	18,842 +14,609	+345%	+$1.36M	0.31%	72
2023 Q4	$378K	Buy	+4,233	New	+$314K	0.07%	164

Other funds holding XBI

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

PSP Research Newtown Square, Pennsylvania $188M AUM

AAS

Annex Advisory Services Brookfield, Wisconsin $5.86B AUM 21.83% 1-Year Est. Return

WAM

Weatherly Asset Management Del Mar, California $1.4B AUM 36.32% 1-Year Est. Return

RFM

Royal Fund Management Lady Lake, Florida $1.2B AUM 32.21% 1-Year Est. Return

NHFG

New Harbor Financial Group Worcester, Massachusetts $633M AUM 37.53% 1-Year Est. Return

MFS

Madrona Financial Services Everett, Washington $543M AUM 30.87% 1-Year Est. Return

LRPA

L. Roy Papp & Associates Phoenix, Arizona $951M AUM 29.05% 1-Year Est. Return

SGH

Sivik Global Healthcare Greenwich, Connecticut $132M AUM 24.1% 1-Year Est. Return

EWM

Edge Wealth Management New York $594M AUM 24.92% 1-Year Est. Return

Titleist Asset Management's XBI Position: Q2 2026 in Review

Titleist Asset Management reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 0.42% in Q2 2026, selling an estimated $2.84K and leaving 5,016 shares worth $794K. The position accounts for 0.05% of the portfolio, ranked #223.

Titleist Asset Management first reported a position in XBI in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.81M in Q2 2024. 260 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Titleist Asset Management held 5,016 shares of State Street SPDR S&P Biotech ETF worth $794K as of Q2 2026.
Titleist Asset Management sold 21 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $2.84K.
State Street SPDR S&P Biotech ETF made up 0.05% of Titleist Asset Management's portfolio in Q2 2026, its #223 holding.
Titleist Asset Management first reported a position in State Street SPDR S&P Biotech ETF in Q4 2023 and has held it in 11 quarters since.
Titleist Asset Management's State Street SPDR S&P Biotech ETF position peaked at $1.81M in Q2 2024.
260 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Titleist Asset Management's 13F filing for Q2 2026, filed 20 Jul 2026.